| Date Checked | 2025-12-21 23:35:29 |
|---|---|
| Graham Number | (PB)nan vs (PE)0.00 |
| Over / Under Value Percentage | 0.00% vs 0.00% |
| Dividend Yield | 0.00% |
| Dividend Date | None |
| Symbol | BEAM |
| AssetType | Common Stock |
| Name | Beam Therapeutics Inc |
| Description | Beam Therapeutics Inc. is a pioneering biotechnology company headquartered in Cambridge, Massachusetts, dedicated to advancing precision genetic therapies for severe and often life-threatening diseases. Leveraging cutting-edge gene-editing technologies such as base editing, Beam is focused on developing targeted treatments that directly address the underlying causes of genetic disorders. With a strong pipeline of innovative therapies, the company is poised to significantly improve patient outcomes and redefine treatment paradigms within the genetic therapeutics landscape, reinforcing its leadership in this rapidly evolving sector. As Beam advances its clinical programs, it remains committed to meeting the complex needs of patients and healthcare providers alike. |
| CIK | 1745999 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | BIOTECHNOLOGY |
| Address | 238 MAIN STREET, CAMBRIDGE, MA, UNITED STATES, 02142 |
| OfficialSite | https://beamtx.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 2696189000 |
| EBITDA | -444216000 |
| PERatio | 0 |
| PEGRatio | None |
| BookValue | 9.8 |
| DividendPerShare | None |
| EPS | -4.41 |
| RevenuePerShareTTM | 0.593 |
| ProfitMargin | 0 |
| OperatingMarginTTM | -13.08 |
| ReturnOnAssetsTTM | -0.235 |
| ReturnOnEquityTTM | -0.472 |
| RevenueTTM | 55701000 |
| GrossProfitTTM | -356086016 |
| DilutedEPSTTM | -4.41 |
| QuarterlyEarningsGrowthYOY | 0 |
| QuarterlyRevenueGrowthYOY | -0.32 |
| AnalystTargetPrice | 45.93 |
| AnalystRatingStrongBuy | 1 |
| AnalystRatingBuy | 13 |
| AnalystRatingHold | 2 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | - |
| ForwardPE | - |
| PriceToSalesRatioTTM | 48.4 |
| PriceToBookRatio | 2.791 |
| EVToRevenue | 31.82 |
| EVToEBITDA | -7.03 |
| Beta | 2.216 |
| 52WeekHigh | 35.25 |
| 52WeekLow | 13.53 |
| 50DayMovingAverage | 25.13 |
| 200DayMovingAverage | 20.99 |
| SharesOutstanding | 101475000 |
| SharesFloat | 87387000 |
| PercentInsiders | 1.189 |
| PercentInstitutions | 102.076 |
| ExDividendDate | None |
| naga | 0 |
| etoro | 0 |
| dateChecked | 2025-12-21 23:35:29 |
| fresh | 1 |